CA2339992A1 - Orally disintegrable tablet forming a viscous slurry - Google Patents
Orally disintegrable tablet forming a viscous slurry Download PDFInfo
- Publication number
- CA2339992A1 CA2339992A1 CA002339992A CA2339992A CA2339992A1 CA 2339992 A1 CA2339992 A1 CA 2339992A1 CA 002339992 A CA002339992 A CA 002339992A CA 2339992 A CA2339992 A CA 2339992A CA 2339992 A1 CA2339992 A1 CA 2339992A1
- Authority
- CA
- Canada
- Prior art keywords
- viscous slurry
- tablet forming
- orally disintegrable
- disintegrable tablet
- mouth
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
Abstract
A dosage form which rapidly disintegrates in the mouth and forms a viscous slurry of either microcapsules or a powder is described. The rapidly disintegrating dosage form is meant for direct oral administration by placing a tablet or capsule in the mouth of a patient. Upon disintegration, a viscosity of the resulting slurry increases so as to form an organoleptically pleasant viscous material which retards the spread of insoluble materials including the drug.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9626598P | 1998-08-12 | 1998-08-12 | |
US60/096,265 | 1998-08-12 | ||
US09/372,738 | 1999-08-11 | ||
US09/372,738 US6368625B1 (en) | 1998-08-12 | 1999-08-11 | Orally disintegrable tablet forming a viscous slurry |
PCT/US1999/018400 WO2000009090A1 (en) | 1998-08-12 | 1999-08-12 | Orally disintegrable tablet forming a viscous slurry |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2339992A1 true CA2339992A1 (en) | 2000-02-24 |
CA2339992C CA2339992C (en) | 2006-01-03 |
Family
ID=26791503
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002339992A Expired - Fee Related CA2339992C (en) | 1998-08-12 | 1999-08-12 | Orally disintegrable tablet forming a viscous slurry |
Country Status (9)
Country | Link |
---|---|
US (1) | US6368625B1 (en) |
EP (1) | EP1104288B1 (en) |
JP (1) | JP2002522471A (en) |
AT (1) | ATE326951T1 (en) |
AU (1) | AU742049B2 (en) |
CA (1) | CA2339992C (en) |
DE (1) | DE69931498T2 (en) |
ES (1) | ES2265188T3 (en) |
WO (1) | WO2000009090A1 (en) |
Families Citing this family (91)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8071128B2 (en) | 1996-06-14 | 2011-12-06 | Kyowa Hakko Kirin Co., Ltd. | Intrabuccally rapidly disintegrating tablet and a production method of the tablets |
US7727552B1 (en) | 1997-03-28 | 2010-06-01 | Eisai R&D Management Co., Ltd. | Oral pharmaceutical preparations decreased in bitterness by masking |
US20030118645A1 (en) * | 1998-04-29 | 2003-06-26 | Pather S. Indiran | Pharmaceutical compositions for rectal and vaginal administration |
US6974590B2 (en) * | 1998-03-27 | 2005-12-13 | Cima Labs Inc. | Sublingual buccal effervescent |
US20030091629A1 (en) * | 1998-03-27 | 2003-05-15 | Cima Labs Inc. | Sublingual buccal effervescent |
SE9802973D0 (en) | 1998-09-03 | 1998-09-03 | Astra Ab | Immediate release tablet |
US10179130B2 (en) | 1999-10-29 | 2019-01-15 | Purdue Pharma L.P. | Controlled release hydrocodone formulations |
EP2295043A1 (en) | 1999-10-29 | 2011-03-16 | Euro-Celtique S.A. | Controlled release hydrocodone formulations |
ES2327898T3 (en) * | 2000-03-01 | 2009-11-05 | EISAI R&D MANAGEMENT CO., LTD. | RAPID DISINTEGRATION TABLET CONTAINING POLI (VINYL ALCOHOL). |
JP4698000B2 (en) * | 2000-06-27 | 2011-06-08 | 旭化成ケミカルズ株式会社 | Easily water-soluble drug-containing tablets |
KR101167465B1 (en) | 2000-10-30 | 2012-07-27 | 유로-셀티크 소시에떼 아노뉨 | Controlled release hydrocodone formulations |
US7799342B2 (en) * | 2000-12-06 | 2010-09-21 | Wyeth Llc | Fast dissolving tablet |
US9358214B2 (en) | 2001-10-04 | 2016-06-07 | Adare Pharmaceuticals, Inc. | Timed, sustained release systems for propranolol |
AU2002302890A1 (en) * | 2002-02-04 | 2003-12-02 | Ranbaxy Laboratories Limited | Hydrodynamically balancing oral drug delivery system with biphasic release |
GB0203984D0 (en) * | 2002-02-20 | 2002-04-03 | Mach Ind Etablissements | Comsumable container |
SI21221A (en) * | 2002-06-21 | 2003-12-31 | LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. | Quickly decomposable tablets |
GB0217056D0 (en) * | 2002-07-23 | 2002-08-28 | Ass Octel | Use |
DE10244504A1 (en) * | 2002-09-25 | 2004-04-08 | Capsulution Nanoscience Ag | Quick-release dosage form with poorly soluble active ingredient |
US8367111B2 (en) * | 2002-12-31 | 2013-02-05 | Aptalis Pharmatech, Inc. | Extended release dosage forms of propranolol hydrochloride |
WO2004066924A2 (en) * | 2003-01-24 | 2004-08-12 | Andrx Labs Llc | Novel pharmaceutical formulation containing a proton pump inhibitor and an antacid |
DE10311585A1 (en) * | 2003-03-14 | 2004-09-23 | Basf Ag | Adsorbates for use in human or animal nutrition or cosmetics are produced by introducing material to be adsorbed together with stabilizer on to carrier |
MXPA05009886A (en) * | 2003-03-14 | 2006-05-04 | Nirmal Mulye | A process for preparing sustained release tablets. |
WO2004098571A1 (en) * | 2003-04-30 | 2004-11-18 | Zicam, Llc | Cold remedy composition comprising zinc salts |
CN1819819B (en) | 2003-05-07 | 2011-03-09 | 株式会社三养社 | Highly plastic granules for making fast melting tablets |
US20040265372A1 (en) * | 2003-06-27 | 2004-12-30 | David Wynn | Soft tablet containing high molecular weight cellulosics |
US20040265373A1 (en) * | 2003-06-27 | 2004-12-30 | David Wynn | Soft tablet containing high molecular weight cellulosics |
CA2531637A1 (en) * | 2003-07-23 | 2005-02-03 | L. Perrigo Company | Cellulosic fiber containing composition |
US7390503B1 (en) | 2003-08-22 | 2008-06-24 | Barr Laboratories, Inc. | Ondansetron orally disintegrating tablets |
JP4740740B2 (en) * | 2003-12-09 | 2011-08-03 | 大日本住友製薬株式会社 | Drug-containing particles and solid preparation containing the particles |
WO2005065317A2 (en) * | 2003-12-31 | 2005-07-21 | Cima Labs Inc. | Effervescent oral fentanyl dosage form |
US20070036853A1 (en) * | 2003-12-31 | 2007-02-15 | Cima Labs Inc. | Generally linear effervescent oral fentanyl dosage form and methods of administering |
BRPI0418228B8 (en) * | 2003-12-31 | 2021-05-25 | Cima Labs Inc | dosage form, and method of preparing a tablet for buccal, gingival or sublingual administration of fentanyl |
EP1708685B1 (en) * | 2003-12-31 | 2011-03-09 | Cima Labs Inc. | Effervescent oral opiate dosage forms and methods of administering oxycodone |
WO2005074658A2 (en) * | 2004-01-30 | 2005-08-18 | Glenmark Pharmaceuticals Inc., Usa | Carbonyl iron pharmaceutical dosage forms for the treatment of iron-deficiency anemia |
US20050170014A1 (en) * | 2004-01-30 | 2005-08-04 | Anandi Krishnan | Carbonyl iron pharmaceutical dosage forms for the treatment of iron-deficiency anemia |
KR20130006523A (en) * | 2004-02-17 | 2013-01-16 | 트랜스셉트 파마슈티칼스, 인코포레이티드 | Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof |
US20060003003A1 (en) * | 2004-06-28 | 2006-01-05 | Bakker Johan A | Oral sustained release formulation of tedisamil with gastric retention properties |
US8747895B2 (en) * | 2004-09-13 | 2014-06-10 | Aptalis Pharmatech, Inc. | Orally disintegrating tablets of atomoxetine |
US8252321B2 (en) | 2004-09-13 | 2012-08-28 | Chrono Therapeutics, Inc. | Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like |
JP5254616B2 (en) | 2004-09-13 | 2013-08-07 | クロノ セラピューティクス、インコーポレイテッド | Biosynchronous transdermal drug delivery |
US9884014B2 (en) | 2004-10-12 | 2018-02-06 | Adare Pharmaceuticals, Inc. | Taste-masked pharmaceutical compositions |
EP1802285B1 (en) | 2004-10-21 | 2013-02-27 | Aptalis Pharmatech, Inc. | Taste-masked pharmaceutical compositions with gastrosoluble pore-formers |
US20060105038A1 (en) * | 2004-11-12 | 2006-05-18 | Eurand Pharmaceuticals Limited | Taste-masked pharmaceutical compositions prepared by coacervation |
EP1830814B1 (en) * | 2005-01-06 | 2009-07-01 | Cima Labs Inc. | Taste masking system for non-plasticizing drugs |
US9161918B2 (en) | 2005-05-02 | 2015-10-20 | Adare Pharmaceuticals, Inc. | Timed, pulsatile release systems |
US20070287740A1 (en) | 2005-05-25 | 2007-12-13 | Transcept Pharmaceuticals, Inc. | Compositions and methods of treating middle-of-the night insomnia |
KR20080031208A (en) * | 2005-05-25 | 2008-04-08 | 트랜스셉트 파마슈티칼스, 인코포레이티드 | Solid compositions and methods for treating middle-of-the night insomnia |
US20070225322A1 (en) * | 2005-05-25 | 2007-09-27 | Transoral Pharmaceuticals, Inc. | Compositions and methods for treating middle-of-the night insomnia |
WO2014007972A2 (en) | 2012-06-15 | 2014-01-09 | Nova Southeastern University | Epinephrine nanoparticles, methods of fabrication thereof, and methods for use thereof for treatment of conditions responsive to epinphrine |
US9877921B2 (en) | 2005-09-09 | 2018-01-30 | Nova Southeastern University | Epinephrine nanoparticles, methods of fabrication thereof, and methods for use thereof for treatment of conditions responsive to epinephrine |
US20070059361A1 (en) * | 2005-09-09 | 2007-03-15 | University Of Manitoba | Fast-disintegrating epinephrine tablets for buccal or sublingual administration |
US20160045457A1 (en) | 2005-09-09 | 2016-02-18 | Ousama Rachid | Epinephrine fine particles and methods for use thereof for treatment of conditions responsive to epinephrine |
AU2006311826C1 (en) * | 2005-11-03 | 2011-06-16 | Redpoint Bio Corporation | Hydrazone derivatives and uses thereof |
US8497258B2 (en) | 2005-11-12 | 2013-07-30 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
US7811604B1 (en) | 2005-11-14 | 2010-10-12 | Barr Laboratories, Inc. | Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same |
US7427414B2 (en) * | 2006-01-18 | 2008-09-23 | Astron Research Limited | Modified release oral dosage form using co-polymer of polyvinyl acetate |
US20070281014A1 (en) * | 2006-06-01 | 2007-12-06 | Cima Labs, Inc. | Prednisolone salt formulations |
WO2007143674A2 (en) * | 2006-06-05 | 2007-12-13 | Verus Pharmaceuticals, Inc. | Methods for buccal, lingual or sublingual dosing regimens of epinephrine for the treatment of allergic emergencies |
WO2007143676A2 (en) * | 2006-06-05 | 2007-12-13 | Verus Pharmaceuticals, Inc. | Epinephrine dosing regimens comprising buccal, lingual or sublingual and injectable dosage forms |
US20080069891A1 (en) | 2006-09-15 | 2008-03-20 | Cima Labs, Inc. | Abuse resistant drug formulation |
CA2659465A1 (en) * | 2006-08-22 | 2008-02-28 | Redpoint Bio Corporation | Heterocyclic compounds as sweetener enhancers |
US8445018B2 (en) | 2006-09-15 | 2013-05-21 | Cima Labs Inc. | Abuse resistant drug formulation |
WO2008033545A2 (en) * | 2006-09-15 | 2008-03-20 | Redpoint Bio Corporation | Triphenylphosphine oxide derivatives and uses thereof |
US20080153845A1 (en) * | 2006-10-27 | 2008-06-26 | Redpoint Bio Corporation | Trpv1 antagonists and uses thereof |
JP5649305B2 (en) * | 2006-12-20 | 2015-01-07 | テバ ウィメンズ ヘルス インコーポレイテッド | Orally disintegrating solid dosage form containing progestin and method for producing and using the same |
CA2677230A1 (en) * | 2007-02-02 | 2008-08-14 | Redpoint Bio Corporation | Use of a trpm5 inhibitor to regulate insulin and glp-1 release |
US20100010031A1 (en) | 2007-02-09 | 2010-01-14 | Yum Ii Su | Transoral dosage forms comprising sufentanil and naloxone |
ES2521494T3 (en) | 2007-04-02 | 2014-11-12 | Parkinson's Institute | Methods and compositions for reducing the side effects of therapeutic treatments |
JP2011507853A (en) | 2007-12-20 | 2011-03-10 | テバ ウィメンズ ヘルス インコーポレイテッド | Dosage regimens and pharmaceutical compositions and packages for emergency contraception |
WO2010077878A1 (en) * | 2008-12-15 | 2010-07-08 | Fleming And Company, Pharmaceuticals | Rapidly dissolving vitamin formulation and methods of using the same |
US20100163805A1 (en) * | 2008-12-31 | 2010-07-01 | Youngtack Shim | Agent-containing media and methods therefor |
US20110097401A1 (en) * | 2009-06-12 | 2011-04-28 | Meritage Pharma, Inc. | Methods for treating gastrointestinal disorders |
WO2011028671A1 (en) | 2009-09-04 | 2011-03-10 | Redpoint Bio Corporation | Sweetness enhancers including rebaudioside a or d |
CN102595932B (en) | 2009-09-22 | 2014-07-16 | 红点生物公司 | Novel polymorphs of rebaudioside C and methods for making and using the same |
AU2010325746B2 (en) | 2009-12-02 | 2016-02-25 | Adare Pharmaceuticals S.R.L. | Fexofenadine microcapsules and compositions containing them |
TW201127375A (en) * | 2010-01-08 | 2011-08-16 | Eurand Inc | Taste masked topiramate composition and an orally disintegrating tablet comprising the same |
US20120322884A1 (en) | 2010-03-01 | 2012-12-20 | University Of Manitoba | Epinephrine nanoparticles, methods of fabrication thereof, and methods for use thereof for treatment of conditions responsive to epinephrine |
JP2013526523A (en) | 2010-05-11 | 2013-06-24 | シマ ラブス インク. | Alcohol-resistant sustained release oral dosage form containing metoprolol |
US20130017259A1 (en) | 2011-07-06 | 2013-01-17 | The Parkinson's Institute | Compositions and Methods for Treatment of Symptoms in Parkinson's Disease Patients |
WO2013022881A1 (en) | 2011-08-08 | 2013-02-14 | International Flavors & Fragrances Inc. | Compositions and methods for the biosynthesis of vanillin or vanillin beta-d-glucoside |
CA2853084C (en) | 2011-10-21 | 2022-04-26 | Nova Southeastern University | Epinephrine nanoparticles, methods of fabrication thereof, and methods for use thereof for treatment of conditions responsive to epinephrine |
WO2014145699A1 (en) * | 2013-03-15 | 2014-09-18 | New Jersey Institute Of Technology | System and method for fabrication of uniform polymer films containing nano and micro particles via continuous drying process |
HRP20211286T1 (en) | 2013-03-22 | 2021-12-24 | Nova Southeastern University | Epinephrine fine particles and methods for use thereof for treatment of conditions responsive to epinephrine |
EP3068227A4 (en) * | 2013-11-11 | 2017-06-21 | Forest Laboratories Holdings Limited | Compositions and methods of treatment comprising fosfomycin disodium |
EP2880992A3 (en) | 2013-12-05 | 2015-06-17 | International Flavors & Fragrances Inc. | Rebaudioside C and its stereoisomers as natural product sweetness enhancers |
US10213586B2 (en) | 2015-01-28 | 2019-02-26 | Chrono Therapeutics Inc. | Drug delivery methods and systems |
JP2018511127A (en) | 2015-03-12 | 2018-04-19 | クロノ セラピューティクス インコーポレイテッドChrono Therapeutics Inc. | Craving input and support system |
US10292977B2 (en) | 2016-04-11 | 2019-05-21 | Neurocea, LLC | Compositions and methods for treatment related to fall and fall frequency in neurodegenerative diseases |
US10143687B2 (en) | 2016-04-11 | 2018-12-04 | Neurocea, LLC | Compositions and methods for treatment related to fall and fall frequency in neurodegenerative diseases |
JP2020503950A (en) | 2017-01-06 | 2020-02-06 | クロノ セラピューティクス インコーポレイテッドChrono Therapeutics Inc. | Device and method for transdermal drug delivery |
WO2019232077A1 (en) | 2018-05-29 | 2019-12-05 | Chrono Therapeutics Inc. | Drug delivery methods and systems |
Family Cites Families (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3011950A (en) | 1959-05-19 | 1961-12-05 | Colgate Palmolive Co | Liquid composition containing discrete gaseous bodies |
US3142621A (en) | 1961-11-02 | 1964-07-28 | Ciba Geigy Corp | Alginate suspensions of oral pharmaceutical compositions with improved taste qualities |
US3456049A (en) | 1965-05-25 | 1969-07-15 | Ciba Geigy Corp | Gradual-release tablet |
US3885027A (en) * | 1971-04-12 | 1975-05-20 | West Laboratories Inc | Orally administered drug composition for therapy in the treatment of narcotic drug addiction |
DE2530563C2 (en) | 1975-07-09 | 1986-07-24 | Bayer Ag, 5090 Leverkusen | Analgesic drugs with reduced potential for abuse |
US4414198A (en) | 1982-04-23 | 1983-11-08 | Joseph Michaelson | Rapidly disintegrable tablet composition and method |
US4454110A (en) | 1982-05-24 | 1984-06-12 | Forsyth Dental Infirmary For Children | Self-gelling liquid composition for topical application in the oral cavity |
US4963367A (en) | 1984-04-27 | 1990-10-16 | Medaphore, Inc. | Drug delivery compositions and methods |
JPS6124516A (en) | 1984-07-12 | 1986-02-03 | Fujisawa Pharmaceut Co Ltd | Long active tablet |
US4610870A (en) | 1984-10-05 | 1986-09-09 | E. R. Squibb & Sons, Inc. | Controlled release formulation |
GB8426152D0 (en) | 1984-10-16 | 1984-11-21 | Reckitt & Colmann Prod Ltd | Medicinal compositions |
US5288497A (en) | 1985-05-01 | 1994-02-22 | The University Of Utah | Compositions of oral dissolvable medicaments |
US4687662A (en) * | 1985-08-30 | 1987-08-18 | Warner-Lambert Company | Therapeutic effervescent composition |
US4710384A (en) | 1986-07-28 | 1987-12-01 | Avner Rotman | Sustained release tablets made from microcapsules |
US5624683A (en) | 1986-08-06 | 1997-04-29 | Eisai Co., Ltd. | Sustained-release multi-granule tablet |
US5288500A (en) | 1987-03-13 | 1994-02-22 | Benzon Pharma A/S | Oral composition containing particles comprising an active substance |
US4950689A (en) | 1987-03-31 | 1990-08-21 | Yang Robert K | Pectin delivery system |
US5215752A (en) | 1988-03-17 | 1993-06-01 | Vectorpharma International S.P.A. | Pharmaceutical tablets and capsule granulates of scleroglucan and active substance |
US5273823A (en) | 1988-10-11 | 1993-12-28 | The Dow Chemical Company | Shaped articles containing copolymers of polybenzazoles |
US4883660A (en) | 1988-10-17 | 1989-11-28 | Thames Pharmacal Co., Inc. | Gel bases for pharmaceutical compositions |
US5133974A (en) | 1989-05-05 | 1992-07-28 | Kv Pharmaceutical Company | Extended release pharmaceutical formulations |
US5102664A (en) | 1989-07-19 | 1992-04-07 | Day Charles E | Good-tasting gritty drug formulations |
US5558880A (en) | 1989-12-22 | 1996-09-24 | Janssen Pharmaceutica Inc. | Pharmaceutical and other dosage forms |
SE9003904D0 (en) | 1990-12-07 | 1990-12-07 | Astra Ab | METHOD FOR THE MANUFACTURE OF A PHARMACEUTICAL DOSAGE FORM |
US5464632C1 (en) | 1991-07-22 | 2001-02-20 | Prographarm Lab | Rapidly disintegratable multiparticular tablet |
CA2116563C (en) | 1991-08-30 | 2001-07-03 | Yoji Ito | Dry gel pharmaceutical composition |
US5215758A (en) | 1991-09-11 | 1993-06-01 | Euroceltique, S.A. | Controlled release matrix suppository for pharmaceuticals |
US5192802A (en) | 1991-09-25 | 1993-03-09 | Mcneil-Ppc, Inc. | Bioadhesive pharmaceutical carrier |
US5318780A (en) | 1991-10-30 | 1994-06-07 | Mediventures Inc. | Medical uses of in situ formed gels |
US5545423A (en) | 1991-11-25 | 1996-08-13 | Vivorx, Inc. | Cytoprotective, biocompatible, retrievable macrocapsule containment systems for biologically active materials |
US5368862A (en) | 1991-12-18 | 1994-11-29 | Merck & Co., Inc. | Sustained release tablets containing alginate |
EP0627218B1 (en) * | 1992-02-18 | 2001-12-19 | Nippon Shinyaku Company, Limited | Process for producing fast soluble tablets and fast soluble tablets comprising xylitol |
US5422122A (en) | 1992-08-04 | 1995-06-06 | Eurand America, Incorporated | Controlled release potassium chloride tablet |
IL104283A (en) | 1992-12-30 | 1996-12-05 | Agis Ind 1983 Ltd | Non-emulsion antiviral topical pharmaceutical composition comprising acyclovir an aqueous gel agent and an alkali oleate |
US5562909A (en) | 1993-07-12 | 1996-10-08 | Massachusetts Institute Of Technology | Phosphazene polyelectrolytes as immunoadjuvants |
US5595761A (en) | 1994-01-27 | 1997-01-21 | The Board Of Regents Of The University Of Oklahoma | Particulate support matrix for making a rapidly dissolving tablet |
US5595760A (en) | 1994-09-02 | 1997-01-21 | Delab | Sustained release of peptides from pharmaceutical compositions |
FR2732217B1 (en) * | 1995-03-29 | 1997-06-06 | Hesnard Xavier | SOLID ADMINISTRATION FORM FOR ORAL USE |
JP2919771B2 (en) * | 1995-04-17 | 1999-07-19 | 佐藤製薬株式会社 | Method for producing fast-dissolving tablet and fast-dissolving tablet produced by the method |
US20010014340A1 (en) * | 1996-06-14 | 2001-08-16 | Motohiro Ohta | Intrabuccally rapidly disintegrating tablet |
ATE400299T1 (en) * | 1996-07-12 | 2008-07-15 | Daiichi Seiyaku Co | RAPIDLY DEGRADING, PRESSURE-FORMED MATERIALS AND THE PROCESS FOR THEIR PRODUCTION |
FR2753097A1 (en) * | 1996-09-11 | 1998-03-13 | Barrau Francois | Solid dosage form giving controlled viscosity solution or dispersion |
KR100353304B1 (en) * | 1996-10-01 | 2002-09-30 | 에스알아이 인터내셔널 | Taste-masked microcapsule compositions and methods of manufacture |
JPH10182436A (en) * | 1996-10-31 | 1998-07-07 | Takeda Chem Ind Ltd | Solid medicinal preparation |
JPH10167958A (en) * | 1996-12-09 | 1998-06-23 | Sankyo Co Ltd | Loxoprofen sodium-containing oral cavity promptly soluble preparation and its production |
US5728401A (en) * | 1997-04-16 | 1998-03-17 | Ranbaxy Laboratories, Ltd. | Effervescent ranitidine formulations |
-
1999
- 1999-08-11 US US09/372,738 patent/US6368625B1/en not_active Expired - Fee Related
- 1999-08-12 EP EP99941105A patent/EP1104288B1/en not_active Expired - Lifetime
- 1999-08-12 WO PCT/US1999/018400 patent/WO2000009090A1/en active IP Right Grant
- 1999-08-12 JP JP2000564593A patent/JP2002522471A/en active Pending
- 1999-08-12 AU AU54823/99A patent/AU742049B2/en not_active Ceased
- 1999-08-12 DE DE69931498T patent/DE69931498T2/en not_active Expired - Lifetime
- 1999-08-12 AT AT99941105T patent/ATE326951T1/en not_active IP Right Cessation
- 1999-08-12 CA CA002339992A patent/CA2339992C/en not_active Expired - Fee Related
- 1999-08-12 ES ES99941105T patent/ES2265188T3/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
WO2000009090A1 (en) | 2000-02-24 |
ES2265188T3 (en) | 2007-02-01 |
DE69931498T2 (en) | 2007-03-01 |
AU742049B2 (en) | 2001-12-13 |
DE69931498D1 (en) | 2006-06-29 |
EP1104288B1 (en) | 2006-05-24 |
JP2002522471A (en) | 2002-07-23 |
ATE326951T1 (en) | 2006-06-15 |
US6368625B1 (en) | 2002-04-09 |
CA2339992C (en) | 2006-01-03 |
AU5482399A (en) | 2000-03-06 |
EP1104288A4 (en) | 2003-04-16 |
EP1104288A1 (en) | 2001-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2339992A1 (en) | Orally disintegrable tablet forming a viscous slurry | |
NZ507566A (en) | Formulation of fast-dissolving efavirenz capsules or tablets using super-disintegrants | |
TWI271198B (en) | Tables disintegrating rapidly in the oral cavity | |
HK1050839A1 (en) | Use of pharmaceutical compositions comprising oxcarbazepine in the fasted state | |
WO2001041770A3 (en) | Nanoparticulate eplerenone compositions | |
WO2002045684A3 (en) | Rapidly dispersing pharmaceutical composition comprising effervescent agents | |
ATE215816T1 (en) | SOLID ORAL MEDICINAL FORM | |
WO1999059544A3 (en) | Orally disintegrable tablets | |
MY118371A (en) | Tetrahydrolipstatin containing compositions | |
EP1566174A3 (en) | Flash-melt oral dosage formulation | |
SG149667A1 (en) | Extended release oral dosage composition | |
DE60121570D1 (en) | ORAL FASCINATING, FIXED PHARMACEUTICAL FORMS TO BE APPLIED ORIGINALLY | |
WO2003047519A3 (en) | 'compressed annular tablet with molded triturate tablet for oral and intraoral' | |
DE69615704T2 (en) | BIOADHESIVE SOLID MEDICINE FORM | |
DE69519685T2 (en) | ORAL MEDICINAL PRODUCT WITH DELAYED DELIVERY OF ACTIVE SUBSTANCES | |
JP2002514212A (en) | Cefadroxyl monohydrate tablet formulation | |
HUP0004966A3 (en) | Pharmaceutical composition for oral administration in the form of matrix tablet enabling the prolonged release of trimetazidine | |
CA2383212A1 (en) | Controlled release oral dosage suitable for oral administration | |
WO2005053658A8 (en) | Butylphthalide soft gel capsule and its preparatin procedure | |
MX9706053A (en) | Trimebutine maleate tablet with laminar covering. | |
DE50112438D1 (en) | DENTAL CARE IN PORTION CAPSULES | |
CA2353693A1 (en) | Pharmaceutical composition containing citalopram | |
Allen Jr | Rapid-dissolve technology: An interview with Loyd V. Allen, Jr., PhD, RPh | |
HUP0303178A2 (en) | Methods and compositions for reducing the taste of pharmaceutically active agents | |
HUP0203148A2 (en) | Orally distintegrating composition comprising mirtazapine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |